Treatment of PIAA on human pancreatic islets from T2D patients caused increased expression of cell cycle molecule CCND1 and β-cell differentiation marker PDX1 (Fig. 8E,F). The gene discussed is CCND1; the disease is type 2 diabetes mellitus.